What is denosumab 60 mg injection used for?
Denosumab 60 mg is an injection used to treat bone disease caused by cancer. In practice, it is most commonly used for:
- Prevention of skeletal-related events in patients with bone metastases from solid tumors (for example, breast or prostate cancer that has spread to bone).
- Treatment of giant cell tumor of bone (a rare, aggressive tumor).
How is denosumab 60 mg given and how often?
It is administered by healthcare professionals as a subcutaneous injection (under the skin). The dosing schedule depends on the indication, but denosumab is typically given at set intervals (commonly every 4 weeks for oncology-related bone conditions).
What side effects do people ask about most?
Commonly reported side effects include:
- Low calcium (hypocalcemia), which can be serious
- Fatigue
- Nausea
- Muscle or joint pain
More serious risks that patients and clinicians watch for include:
- Osteonecrosis of the jaw (ONJ) (jaw bone problems, especially after dental procedures)
- Serious infections
- Hypocalcemia, especially in people with kidney impairment
Who should not use it or who needs extra monitoring?
People with certain conditions need careful evaluation before starting or continuing denosumab, especially:
- Kidney disease (higher risk of hypocalcemia)
- Low baseline calcium or vitamin D deficiency (clinicians often correct these first)
- Active dental problems or planned tooth extractions (risk of ONJ is a key concern)
Does it require calcium and vitamin D?
Yes. For denosumab used for bone metastases and similar indications, clinicians typically recommend calcium and vitamin D supplementation to reduce the risk of hypocalcemia.
What about dental care and ONJ risk?
Patients are usually advised to:
- Get dental problems addressed before treatment when possible
- Tell their oncology team before major dental work
- Maintain good oral hygiene during therapy
ONJ risk is one reason dental history and ongoing monitoring matter during treatment.
Is denosumab 60 mg related to Xgeva vs Prolia?
Denosumab is marketed under different brand names depending on the dose and indication. The “60 mg” strength is commonly associated with oncology use (for bone-related cancer conditions). Other denosumab dosing/uses may have different brand labeling.
If you tell me the brand name on your prescription (for example, Xgeva vs Prolia) or the indication your clinician gave, I can match the correct dosing context more precisely.
Patents and availability
If you’re trying to understand the commercial and patent landscape for denosumab (including biosimilar/competition signals for a specific brand or strength), DrugPatentWatch.com is a useful place to check patent status and related filings:
- https://www.drugpatentwatch.com/ (search “denosumab” there)
Quick clarifying question
When you say “denosumab 60 mg injection,” is your prescription for bone metastases (cancer) or for giant cell tumor of bone? The dosing schedule and key monitoring points are similar, but the labeled use can differ.